Early research (Phase 1)Study completedNCT02748837What this trial is testingERY974 in Patient With Advanced Solid TumorsWho this might be right forSolid Tumors Chugai Pharmaceutical 29
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT02354898What this trial is testingBBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Solid TumorsHepatocellular Carcinoma Sumitomo Pharma Co., Ltd. 60
Early research (Phase 1)WithdrawnNCT00601614What this trial is testingVandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06117540What this trial is testingWX390 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Shanghai Jiatan Pharmatech Co., Ltd 70
Early research (Phase 1)Active Not RecruitingNCT05914376What this trial is testingSafety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced TumorsWho this might be right forAdvanced Solid Tumors Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Study completedNCT00849550What this trial is testingSafety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.Who this might be right forUnspecified Adult Solid Tumor, Protocol SpecificCancer Herbert Hurwitz 32
Early research (Phase 1)Study completedNCT04261413What this trial is testingPhase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumors RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. 16
Not applicableStudy completedNCT02724488What this trial is testingSelection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic TherapiesWho this might be right forHead and Neck CancerMelanoma University Health Network, Toronto 14
Early research (Phase 1)Study completedNCT05085548What this trial is testingProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor MalignanciesWho this might be right forAdvanced Pancreatic CancerSolid Tumor Malignancies ProDa BioTech, LLC 46
Early research (Phase 1)Study completedNCT00054548What this trial is testingCombination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT05367778What this trial is testingPhase 1/2 Study of HS-10370 in Patients with Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Jiangsu Hansoh Pharmaceutical Co., Ltd. 176
Testing effectiveness (Phase 2)Looking for participantsNCT05379985What this trial is testingStudy of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASWho this might be right forNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Revolution Medicines, Inc. 754
Early research (Phase 1)Study completedNCT02355535What this trial is testingProcaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Who this might be right forSolid TumorPancreatic Neuroendocrine TumorNeuroendocrine Tumors Vanquish Oncology, Inc. 48
Early research (Phase 1)Ended earlyNCT04729725What this trial is testingSAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIALWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00880308What this trial is testingDose Finding and Safety of Oral LDE225 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma Novartis Pharmaceuticals 103
Early research (Phase 1)Study completedNCT00400023What this trial is testingA Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid TumorsWho this might be right forTumors Taiho Oncology, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123What this trial is testingTesting AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00622674What this trial is testingBortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+5 more Masonic Cancer Center, University of Minnesota 37
Testing effectiveness (Phase 2)Looking for participantsNCT06682780What this trial is testingA Phase I/II Study of LM-2417 in Subjects With Advanced Solid TumoursWho this might be right forAdvanced Solid Tumor LaNova Medicines Limited 320